Prognostic value of long non-coding RNA plasmacytoma variant translocation1 in human solid tumors: A meta-analysis

14Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Plasmacytoma variant translocation 1 (PVT1) is highly expressed in a variety of cancer tissues and is related to the clinicopathological features and prognosis. However, the prognostic value of PVT1 is still controversial. Therefore, this systematic evaluation and metaanalysis were performed to evaluate the relationship between PVT1 expression and clinicopathological features. PubMed, EMBASE, Web of science, and Cochrane library databases were searched for literature collection according to inclusion criteria and exclusion criteria. The pooled hazard ratios (HRs) or odds ratios (ORs) were used to evaluate the association between PVT1 expression and overall survival, tumor size, tumor-node-metastasis (TNM) stage, lymph node metastasis, and distant metastasis. A total of 39 articles including 3974 patients were included in the study. The results showed that the expression of PVT1 was closely related to the overall survival rate of cancers (HR=1.64, 95% confidence interval [CI]: 1.50-1.78, P

Cite

CITATION STYLE

APA

Zou, B., Wang, D., Xu, K., Liu, J. L., Yuan, D. Y., Meng, Z., & Zhang, B. (2019). Prognostic value of long non-coding RNA plasmacytoma variant translocation1 in human solid tumors: A meta-analysis. Medicine (United States), 98(27). https://doi.org/10.1097/MD.0000000000016087

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free